News as it is -

Best Media Info

Partner Content

Pernod Ricard South Asia and India MD Thibault Cuny steps down owing to health reasons

Guettat, Chairman and CEO, Pernod Ricard Asia, will hold the charge in the interim

Thibault Cuny

Thibault Cuny, MD and CEO, Pernod Ricard South Asia (including India) has stepped down from his role as of today due to medical reasons.

As per the company, Cuny has been dealing with health concerns over the past couple of years and his decision to take a break from his professional duties is based on medical advice.

He will continue to be employed at Pernod Ricard.

Cuny took over as the MD and CEO, Pernod Ricard South Asia in 2019 after serving Pernod Ricard Brazil in the capacity of President and CEO. He has been with the group on various leadership roles for almost two decades. In his role at Pernod Ricard India, Cuny was actively driving the group’s transformation agenda with accelerated focus on ‘Premiumisation’, ‘Inclusion and Diversity’, ‘Sustainability and Responsibility’ and Ethics and Compliance.

In the interim, Philippe Guettat, Chairman and CEO, Pernod Ricard Asia will hold charge of Pernod Ricard South Asia, including India.

Guettat said, “Thibault has been steering the company through one of its most significant transformation journeys over the last four years. Despite turbulent times during the pandemic, and challenges owing to his health condition, Pernod Ricard India has witnessed robust growth and steady progress in many critical areas. It disheartens us to see such a strong transformational leader stepping away from a role that he assumed with great passion and vigour. However, health and safety of our people is and always has been the group’s number one priority. We pray for Thibault’s speedy recovery and wish him strength as he continues his medical treatment.” 

The company has begun the process to identify the most suitable leader to take Pernod Ricard India on the next phase of its growth and transformation agenda. A formal announcement regarding the appointment will be made in due course.

Post a Comment